SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and metaanalysis (vol 7, pg 845, 2019)

被引:0
|
作者
Neuen, B. L.
Young, T.
Heerspink, H. J. L.
机构
来源
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 12期
关键词
D O I
10.1016/S2213-8587(19)30354-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E23 / E23
页数:1
相关论文
共 50 条
  • [1] SGLT2 Inhibitors for the Prevention of Kidney Failure in Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (07): : 663 - 664
  • [2] SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    Neuen, Brendan L.
    Young, Tamara
    Heerspink, Hiddo J. L.
    Neal, Bruce
    Perkovic, Vlado
    Billot, Laurent
    Mahaffey, Kenneth W.
    Charytan, David M.
    Wheeler, David C.
    Arnott, Clare
    Bornpoint, Severine
    Levin, Adeera
    Jardine, Meg J.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (11): : 845 - 854
  • [3] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes (vol 17, pg 1521, 2019)
    Evans, Marc
    Hicks, Debbie
    Patel, Dipesh
    Patel, Vinod
    McEwan, Phil
    Dashora, Umesh
    DIABETES THERAPY, 2020, 11 (02) : 571 - 571
  • [4] SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
    Thomas, Merlin C.
    Neuen, Brendon L.
    Twigg, Stephen M.
    Cooper, Mark E.
    Badve, Sunil, V
    ENDOCRINE CONNECTIONS, 2023, 12 (08)
  • [5] A Systematic Review of the Comparative Effectiveness and Safety of SGLT2 Inhibitors in Type 2 Diabetes
    Tseng, Eva
    Bolen, Shari
    Segal, Jodi B.
    Wilson, Lisa
    Hutfless, Susan
    Maruthur, Nisa M.
    DIABETES, 2015, 64 : A661 - A662
  • [6] Heart failure protection by SGLT2 inhibitors in patients with type 2 diabetes mellitus: evidence and possible mechanisms A systematic review
    Rieth, Andreas J.
    Hamm, Christian W.
    Wanner, Christoph
    Mitrovic, Veselin
    Keller, Till
    HERZ, 2021, 46 : 151 - 158
  • [7] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [9] ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Mi, D.
    Pan, P.
    Chen, S.
    Chen, S.
    Peng, F.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 88 - 88
  • [10] SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis
    Guo, Man
    Ding, Jingya
    Li, Jingsong
    Wang, Jiying
    Zhang, Ting
    Liu, Cuiping
    Huang, Wei
    Long, Yang
    Gao, Chenlin
    Xu, Yong
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1977 - 1982